Largest health care biotech companies by total debt

Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.

Amgen leads the 11 health care biotech companies ranked by total debt, at NOK 532.9B, ahead of Gilead Sciences (NOK 243.4B) and Biogen (NOK 61.4B). Figures as of 20 Nov 2026, 04:27 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
11
First
AmgenNOK 532.9B
Median
NOK 5.8B
Combined market value
NOK 8.08T
Countries
5
Not ranked
13no total debt on file

Market values as of .

All countries
Health Care
Biotech
NOK
Clear filters
Largest health care biotech companies by total debt
#CompanyTotal debt ↓Market capPriceToday1 yearPrice, 30 daysCountry
1AmgenAMGN · Health CareNOK 532.9BNOK 2.32TNOK 4,282.51 1.14% down 32% up United States
2Gilead SciencesGILD · Health CareNOK 243.4BNOK 2.02TNOK 1,625.19 1.45% down 35% up United States
3BiogenBIIB · Health CareNOK 61.4BNOK 356.5BNOK 2,411.78 1.70% down 49% up United States
4Halozyme TherapeuticsHALO · Health CareNOK 20.9BNOK 103.5BNOK 907.99 2.88% down 39% up United States
5QiagenQGEN · Health CareNOK 16.1BNOK 100BNOK 484.35 0.14% up 9% up Netherlands
6ModernaMRNA · Health CareNOK 5.8BNOK 787.1BNOK 1,945.29 1.29% up 780% up United States
7RepligenRGEN · Health CareNOK 5.3BNOK 106.2BNOK 1,661.89 1.38% down 12% up United States
8Bio-TechneTECH · Health CareNOK 2BNOK 111.5BNOK 709.49 0.07% down 24% up United States
9Adaptive BiotechnologiesADPT · Health CareNOK 1.3BNOK 44.3BNOK 273.74 1.44% down 74% up United States
10Scholar Rock HoldingSRRK · Health CareNOK 973.1MNOK 60BNOK 491.57 4.94% up 26% up United States
11CG OncologyCGON · Health CareNOK 29.3MNOK 71.4BNOK 799.27 2.38% up 97% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total debt is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Total debt is assembled from each company's debt lines and is the least complete of these figures: some companies tag part of their borrowings in ways it misses. Sums are converted from US dollars at today's exchange rate (1 USD = 9.7591 NOK). 13 companies have no total debt on file and are not ranked here.

Questions and answers

Which health care biotech companies rank first by total debt?

Amgen (NOK 532.9B), Gilead Sciences (NOK 243.4B) and Biogen (NOK 61.4B) are the top three of the 11 health care biotech companies ranked by total debt as of 20 Nov 2026, 04:27 UTC.

How many health care biotech companies are in this ranking?

11 are ranked by total debt. 13 more have no total debt on file and are left out rather than ranked at zero.

What are these health care biotech companies worth together?

The 11 health care biotech companies ranked by total debt have a combined market value of NOK 8.08T as of 20 Nov 2026, 04:27 UTC.

What does ranking by total debt measure?

Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.

Cite this page

Funkfolio, “Largest health care biotech companies by total debt”, data as of 20 November 2026. https://funkfolio.com/companies/category/biotech?sector=health-care&by=total-debt

Underlying data: Yahoo Finance; SEC EDGAR.